Hims & Hers: Ready To Outperform Further

Hims & Hers Health, Inc. (NYSE: HIMS ) demonstrated a robust start into 2025 with a 15.5% YTD rally. My intrinsic value calculation suggests that there is still massive potential upside even after the powerful rally of the first half ofAs an investor who started my path five years ago with my own capital, I represent a blend of hands on experience and academic background in corporate finance. Due to my relatively young age I thrive on discovering long-duration growth opportunities and actively seek out oppo ...